Acadian Asset Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-3,668
| Closed | -$79K | – | 1888 |
|
|
2021
Q4 | $79K | Buy |
+3,668
| New | +$79K | ﹤0.01% | 1420 |
|
|
2020
Q1 | – | Sell |
-34,290
| Closed | -$470K | – | 1995 |
|
|
2019
Q4 | $470K | Buy |
34,290
+11,809
| +53% | +$162K | ﹤0.01% | 1094 |
|
|
2019
Q3 | $351K | Hold |
22,481
| – | – | ﹤0.01% | 1179 |
|
|
2019
Q2 | $504K | Buy |
22,481
+10,319
| +85% | +$231K | ﹤0.01% | 1018 |
|
|
2019
Q1 | $831K | Buy |
12,162
+1,984
| +19% | +$136K | ﹤0.01% | 955 |
|
|
2018
Q4 | $538K | Buy |
10,178
+519
| +5% | +$27.4K | ﹤0.01% | 882 |
|
|
2018
Q3 | $656K | Buy |
9,659
+1,768
| +22% | +$120K | ﹤0.01% | 827 |
|
|
2018
Q2 | $934K | Buy |
7,891
+4,819
| +157% | +$570K | ﹤0.01% | 744 |
|
|
2018
Q1 | $254K | Buy |
3,072
+2,261
| +279% | +$187K | ﹤0.01% | 1008 |
|
|
2017
Q4 | $121K | Buy |
811
+429
| +112% | +$64K | ﹤0.01% | 1051 |
|
|
2017
Q3 | $24K | Buy |
382
+18
| +5% | +$1.13K | ﹤0.01% | 1201 |
|
|
2017
Q2 | $17K | Buy |
364
+16
| +5% | +$747 | ﹤0.01% | 1279 |
|
|
2017
Q1 | $21K | Buy |
+348
| New | +$21K | ﹤0.01% | 1365 |
|
|
2016
Q4 | – | Sell |
-220
| Closed | -$16K | – | 1814 |
|
|
2016
Q3 | $16K | Sell |
220
-101
| -31% | -$7.35K | ﹤0.01% | 1179 |
|
|
2016
Q2 | $26K | Sell |
321
-3
| -0.9% | -$243 | ﹤0.01% | 1123 |
|
|
2016
Q1 | $87K | Buy |
+324
| New | +$87K | ﹤0.01% | 1052 |
|